Main Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87K | Hold |
3,571
| – | – | 0.01% | 72 |
|
|
2025
Q1 | $74K | Sell |
3,571
-1,244
| -26% | -$25.8K | 0.01% | 77 |
|
|
2024
Q4 | $113K | Sell |
4,815
-650,326
| -99% | -$15.3M | 0.01% | 72 |
|
|
2024
Q3 | $16.8M | Sell |
655,141
-26,330
| -4% | -$674K | 1.38% | 18 |
|
|
2024
Q2 | $16M | Sell |
681,471
-1,773
| -0.3% | -$41.6K | 1.32% | 23 |
|
|
2024
Q1 | $19.7M | Buy |
683,244
+1,775
| +0.3% | +$51K | 1.68% | 20 |
|
|
2023
Q4 | $22.4M | Buy |
681,469
+678,290
| +21,337% | +$22.3M | 2.19% | 16 |
|
|
2023
Q3 | $89K | Hold |
3,179
| – | – | 0.01% | 80 |
|
|
2023
Q2 | $108K | Sell |
3,179
-1,435
| -31% | -$48.8K | 0.01% | 81 |
|
|
2023
Q1 | $139K | Buy |
4,614
+980
| +27% | +$29.5K | 0.01% | 79 |
|
|
2022
Q4 | $103K | Sell |
3,634
-23,000
| -86% | -$652K | 0.01% | 96 |
|
|
2022
Q3 | $875K | Buy |
26,634
+2,641
| +11% | +$86.8K | 0.11% | 65 |
|
|
2022
Q2 | $756K | Buy |
23,993
+18,965
| +377% | +$598K | 0.09% | 67 |
|
|
2022
Q1 | $231K | Sell |
5,028
-12,696
| -72% | -$583K | 0.02% | 100 |
|
|
2021
Q4 | $1.09M | Buy |
17,724
+13,806
| +352% | +$845K | 0.11% | 65 |
|
|
2021
Q3 | $293K | Sell |
3,918
-7,057
| -64% | -$528K | 0.03% | 85 |
|
|
2021
Q2 | $1.02M | Sell |
10,975
-8
| -0.1% | -$740 | 0.11% | 62 |
|
|
2021
Q1 | $975K | Sell |
10,983
-462
| -4% | -$41K | 0.11% | 62 |
|
|
2020
Q4 | $1.07M | Buy |
11,445
+10,213
| +829% | +$952K | 0.14% | 59 |
|
|
2020
Q3 | $78K | Buy |
1,232
+660
| +115% | +$41.8K | 0.01% | 104 |
|
|
2020
Q2 | $30K | Buy |
+572
| New | +$30K | ﹤0.01% | 100 |
|